Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chaiqin xiaoer qingre
- Development stage
- Unknown
- Lead developer
- Anhui Institute of Pharmaceutical Research
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Chaiqin Xiaoer Qingre is a Traditional Chinese Medicine (TCM) granule formulation developed by the Anhui Institute of Pharmaceutical Research, specifically designed for pediatric use. It is primarily indicated for the treatment of fever and acute upper respiratory tract infections (AURTI) in children. The formulation's name is derived from its two principal herbal components: *Chaihu* (Radix Bupleuri) and *Huangqin* (Radix Scutellariae). These herbs contain active phytochemicals such as saikosaponins and baicalin, which exhibit potent antipyretic, anti-inflammatory, and antiviral activities. The drug functions by inhibiting the production of pro-inflammatory cytokines and prostaglandins, thereby reducing body temperature and alleviating respiratory symptoms. It is widely utilized in China as a standard therapeutic option for childhood respiratory ailments.
- Brand names
- Chaiqin Xiaoer Qingre Keli
- Other names
- Chaiqin Xiaoer Qingre Granules
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on chaiqin xiaoer qingre.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chaiqin xiaoer qingre.